The world’s biggest international organisations rely on us to help them make the right decisions in a fast-changing world. We combine the knowledge, experience and energy of the whole firm to solve our clients’ most complex challenges, wherever and whenever they arise.
Here you’ll find our lawyers’ latest perspectives on the business, legal and wider issues that matter.
Our global teams span specialisms, regions and industries to deliver against three fundamental client needs: transactional, regulatory, risk.
Explaining the culture of a firm is always difficult. But we think ours is special.
Media contacts Awards
Global law firm Freshfields advises Zabka Group (as issuer) and CVC Capital Partners (as a selling shareholder) on the IPO of Zabka Group and its listing on the Warsaw Stock Exchange. The IPO is one ...
Freshfields has received multiple top rankings in the 2025 Legal 500 Latin America guide, an annual guide to the top international law firms in the Latin America market. For the 16th consecutive year...
Global law firm Freshfields is advising Sanofi on its exclusive negotiations with CD&R for the potential purchase and sale of a 50% controlling stake in Opella, its consumer healthcare business. The ...
Freshfields was awarded the Thomas L. Sager Award at MCCA’s Gala on October 15, 2024. The award highlights the commitment of firms building a more diverse, equitable, and inclusive legal industry ...
Caroline Richard, a Washington DC-based partner has been named an International Arbitration MVP by Law360. The Law360 MVP award recognizes attorneys who had the biggest wins and made the most ...
Thirty-three Freshfields partners have been named to Lawdragon’s 500 Dealmakers in America guide. The guide recognizes the M&A, corporate, securities, finance, private equity, tax, corporate ...
Freshfields is representing Zuora (NYSE: ZUO), a leading monetization suite for modern business, on its agreement to be acquired by Silver Lake and GIC in a transaction valued at $1.7 billion. ...
Global law firm Freshfields advises Zentiva on the conclusion of an investment agreement with Apontis Pharma AG, the intended voluntary public purchase offer to be made to the shareholders of Apontis...
